Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

intrauterine re-adhesion risk post TCRA, and the improvement of endometrial growth. Intrauterine adhesions (IUA) are the formation of scar tissues in the endometrial cavity as a result of damages to the endometrial basal layer of the uterus, which...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive...

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, announced the United States Food and Drug Administration (FDA) has cleared an investigational new...

26th Asia-Pacific League of Associations for Rheumatology Congress 2024

to be an exceptional gathering, embracing the vibrant spirit of Singapore and fostering an immersive in-person congress format. Join us as we celebrate not only the remarkable hospitality of our Singaporean colleagues but also commemorate a pivotal...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

the way forward to improve the lives of people living with liver disease around the world. We have helped to transform hepatitis C from a chronic condition into one that can be cured for millions of people. For people living with hepatitis B or D,...

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, announced that it has unified its products...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

medications that help promote adherence and ease of use for patients.” Unidose (UDS) and Bidose (BDS) Technology Platforms: Aptar’s UDS and BDS technology platforms are designed to be robust, reliable and intuitive systems for easy administration...

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials

Thomas Mitro was recruited by Spencer Trask to lead Signal12 as president and chief executive officer. Mitro is the former president and chief operating officer of Aerie Pharmaceuticals, where he grew annual sales to more than $100 million and...

Persist AI and Nivagen partner to develop AI-driven manufacturing for long-acting injectables

to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, using Persist's AI-based formulation technology and Nivagen's manufacturing capabilities. The collaboration aims to simplify and accelerate the...

Stay Protected

and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. For more information please visit,www.Culinary.net

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

T-cell Lymphoma: Cutaneous T-cell lymphoma is a type of cutaneous non-Hodgkin lymphoma (NHL) that comes in a variety of forms and is the most common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune...

Axion BioSystems extends its agreement with Corning®, granting exclusive rights to distribute its award-winning cell counting device.

the development of groundbreaking therapeutics.” Since launching the revolutionary Maestro multielectrode array (MEA) platform in 2008, Axion BioSystems has continuously expanded its line of next-generation live-cell analysis tools to meet the...

Formosa licenses Clobetasol Propionate Ophthalmic Suspension to Apotex for ocular surgery relief

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Canada to the commercialization of clobetasol propionate ophthalmic suspension,...

Sensitech acquires Berlinger & Co. to expand life sciences cold chain solutions

in intelligent climate and energy solutions that matter for people and our planet for generations to come. For more information, visit www.Sensitech.com

Jade Biosciences launches with $80 million to develop transformative autoimmune disease therapies

company is backed by a strong slate of investors who helped fund the company and support its vision of delivering transformative therapies to patients in need." Jade is the fourth company to launch based on assets discovered and developed by...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

commitment to excellence, and flawless execution to drive the future of research and healthcare innovation. For more information, please visit: www.eximiaresearch.com.

Inoviv launches MasterKey™, a customizable platform for multiplexed protein assays

will enable researchers to expedite their research goals, and I'm excited to see Inoviv leverage their advanced platform to further biomarker discovery." The MasterKey™ solution combines the precision of advanced mass spectrometry with the...

Clarivate introduces the new OFF-X™ platform for preclinical and clinical safety intelligence

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the launch of the new OFF-X™ platform. The enhanced solution offers a seamless user experience and unique translational insights. It delivers crucial...

Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe

we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.